Cipher Pharmaceuticals Inc. (TSX:CPH)
Canada · Delayed Price · Currency is CAD 13.95
-0.21 (-1.48%)
Aug 28, 2026, 4:00 PM EST
Cipher Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 9.11 | 7.49 | 17.84 | 39.83 | 28.84 | 20.55 |
Cash & Short-Term Investments | 9.11 | 7.49 | 17.84 | 39.83 | 28.84 | 20.55 |
Cash Growth | -19.65% | -57.99% | -55.21% | 38.11% | 40.34% | 124.76% |
Accounts Receivable | 12.14 | 11.21 | 13.86 | 5.09 | 6.8 | 6.66 |
Receivables | 12.14 | 11.21 | 13.86 | 5.09 | 6.8 | 6.66 |
Inventory | 9.24 | 8.19 | 5.79 | 2.98 | 2.15 | 1.65 |
Prepaid Expenses | 0.49 | 1.16 | 1 | 0.38 | 0.37 | 0.47 |
Total Current Assets | 30.98 | 28.05 | 38.48 | 48.27 | 38.16 | 29.33 |
Property, Plant & Equipment | 0.41 | 0.57 | 0.68 | 0.4 | 0.48 | 0.5 |
Goodwill | 17.45 | 17.45 | 17.45 | 15.71 | 15.71 | 15.71 |
Other Intangible Assets | 69.38 | 72.01 | 78.75 | 1.76 | 2.75 | 3.65 |
Long-Term Deferred Tax Assets | 38.51 | 38.19 | 26.76 | 19.89 | 16.67 | 2.47 |
Long-Term Deferred Charges | 0.16 | 0.24 | 0.39 | - | - | - |
Total Assets | 156.89 | 156.5 | 162.51 | 86.03 | 73.78 | 51.65 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 6.73 | 6.39 | 5.87 | 4.6 | 4.11 | 5.56 |
Current Portion of Leases | 0.24 | 0.29 | 0.28 | 0.09 | 0.1 | 0.06 |
Current Income Taxes Payable | - | 0.01 | 0.05 | - | 4.9 | 6.23 |
Current Unearned Revenue | 12.54 | 18.35 | 13.31 | 0.56 | 0.26 | 0.45 |
Other Current Liabilities | - | 0.01 | 0.36 | - | - | - |
Total Current Liabilities | 19.51 | 25.04 | 19.87 | 5.25 | 9.37 | 12.29 |
Long-Term Debt | - | 5 | 40 | - | - | - |
Long-Term Leases | 0.13 | 0.22 | 0.3 | 0.26 | 0.33 | 0.46 |
Total Liabilities | 19.64 | 30.26 | 60.17 | 5.51 | 9.7 | 12.75 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 28.43 | 27.86 | 27.68 | 18.01 | 17.72 | 18.12 |
Additional Paid-In Capital | 8.05 | 7.79 | 6.53 | 5.76 | 5.36 | 5.09 |
Retained Earnings | 110.29 | 100.11 | 77.65 | 66.27 | 50.52 | 25.2 |
Comprehensive Income & Other | -9.51 | -9.51 | -9.51 | -9.51 | -9.51 | -9.51 |
Shareholders' Equity | 137.25 | 126.24 | 102.34 | 80.52 | 64.08 | 38.9 |
Total Liabilities & Equity | 156.89 | 156.5 | 162.51 | 86.03 | 73.78 | 51.65 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 0.37 | 5.51 | 40.58 | 0.35 | 0.43 | 0.52 |
Net Cash (Debt) | 8.74 | 1.99 | -22.74 | 39.47 | 28.41 | 20.03 |
Net Cash Growth | - | - | - | 38.95% | 41.81% | 174.67% |
Net Cash Per Share | 0.34 | 0.08 | -0.90 | 1.55 | 1.10 | 0.75 |
Filing Date Shares Outstanding | 25.42 | 25.28 | 25.61 | 23.99 | 25.08 | 25.68 |
Total Common Shares Outstanding | 25.42 | 25.28 | 25.6 | 23.99 | 25.06 | 25.94 |
Working Capital | 11.47 | 3.01 | 18.61 | 43.02 | 28.79 | 17.03 |
Book Value Per Share | 5.40 | 4.99 | 4.00 | 3.36 | 2.56 | 1.50 |
Tangible Book Value | 50.43 | 36.78 | 6.14 | 63.05 | 45.62 | 19.54 |
Tangible Book Value Per Share | 1.98 | 1.45 | 0.24 | 2.63 | 1.82 | 0.75 |
Machinery | 0.22 | 0.22 | 0.2 | 0.13 | 0.13 | 0.13 |
Leasehold Improvements | 0.1 | 0.1 | 0.1 | 0.09 | 0.07 | - |